The Ideal Post-Market Survey solution for MedTech
Collect scientifically valid and compliant post-market data using Patient level Survey Solutions, specifically built for medical device and diagnostics post-market surveys under EU MDR and FDA.
Milo allows sponsors to create diaries
Milo Builder accommodates robust reporting and integration. It’s dynamic and fully customizable and can be modeled on multiple devices in real time.
Protocol changes can be made centrally to patient assessments and deployed automatically to all participants. This helps you reduce risk and study delays.
Participants use the Milo App to add diary entries
Milo Patient increases compliance and enhances the patient experience. It’s intuitively designed for Android or iOS using consistent features available online or off.
Whether with a provisioned device or bring your own device (BYOD), Scribe updates studies without requiring patients to download an updated app.
Interface ePRO and eCRF
Milo patient survey Mobile
MILO Investigator survey platorm
MILO Survey Analytics
Custom eCOA library reduces Clinical trial Orthopedic and spine program timelines by 50%
Level 4 high-quality surveys are patient-reported outcomes questionnaires and are intended to measure a patient’s health-related status or quality of life at a single point in time. In addition, level 4 high-quality surveys are self-completed questionnaires and are collected over a short period of time. PROM level 4 information is collected before and after a procedure/surgery and provides an indication of the outcomes or quality of care delivered to patients.
Discover how a large spine sponsor created a customized eCOA library to collect accurate, daily-reported patient data across 13 countries. There was no room for error; each input needed to roll up into one resolution.
/
Case study of the MILO platform
How Regenlab and Unither Pharma Mastered Mid-Study Changes with MILO's Seamless ePRO Integration
MILO’s ePRO solution enabled Regenlab and Unither Pharma to engage with a participant population that might otherwise struggle with a technology solution they had never used before.
Easy-to-use ePRO surveys, accessible to participants on familiar devices, made real-world data collection possible. Native integration with MILO allowed Regenlab and Unither Pharma to collect and manage data seamlessly, conserving budget and IT resources that would typically be spent sourcing and integrating with additional vendors.
ePRO questionnaire
Native ePRO questionnaire created within Milo EDC
Send invitation
Send email (QR code to download app) or login to mobile site
Responsive Survey
Participants fill out the survey on a laptop or mobile device
Notifications
Receive app/email notifications reminding when to take the survey
ePRO Data Capture
ePRO data captured in Milo EDC
Get Started with Milo Today
Transform your site contracting process with Milo’s advanced platform. Contact us today to learn more about how Milo can help you streamline your clinical trials and achieve faster, more efficient results
+93
client satisfied
2+
Weeks Study Start-up
20+
Languages
LEADERSHIP TEAM
Recent Publications
At Eclevar, we pride ourselves on providing comprehensive and innovative solutions to enhance clinical trial management. Our clinical team have recently published several studies focusing on Survey Levels in clinical trials, highlighting the critical role of surveys in collecting real-world data and optimizing trial outcomes.
Wearable Technologies for Children with Chronic Illnesses: An Exploratory Approach.
McErlane F, Davies EH, Ollivier C, Mayhew A, Anyanwu O, Harbottle V, Donald A.Ther Innov Regul Sci. 2021 Jul;55(4):799-806. doi: 10.1007/s43441-021-00278-9. Epub 2021 Apr 12.PMID: 33844190
An algorithmic approach to shoulder pathology.
McErlane F, Davies EH, Ollivier C, Mayhew A, Anyanwu O, Harbottle V, Donald A.Ther Innov Regul Sci. 2021 Jul;55(4):799-806. doi: 10.1007/s43441-021-00278-9. Epub 2021 Apr 12.PMID: 33844190
Demonstrating the feasibility of digital health to support pediatric patients in South Africa.
Davies EH, Fieggen K, Wilmshurst J, Anyanwu O, Burman RJ, Komarzynski S.Epilepsia Open. 2021 Dec;6(4):653-662. doi: 10.1002/epi4.12527. Epub 2021 Sep 2.PMID: 34310860 Free PMC article.